Case Report: Ultrahypofractionated Palliative Breast Radiotherapy for a Fungating Invasive Mammary Carcinoma
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Palliative radiotherapy for symptomatic and intact breast tumors must balance convenience, efficacy, and risk of acute toxicity. This case report presents a patient with metastatic breast cancer and an intact fungating primary tumor. She was treated with an ultrahypofractionated radiation therapy, 26 Gy in 5 consecutive daily fractions, with sequential palliative chemotherapy. This resulted in a minimal toxicity profile and significant reduction of tumor burden and symptoms.
Citing Articles
Lee J, Kim J, Liu M, Bang A, Olson R, Chang J J Breast Cancer. 2024; 27(2):91-104.
PMID: 38529591 PMC: 11065499. DOI: 10.4048/jbc.2024.0004.
References
1.
Vanni G, Pellicciaro M, Materazzo M, Pedini D, Portarena I, Buonomo C
. Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic. Anticancer Res. 2021; 41(5):2689-2696.
DOI: 10.21873/anticanres.15050.
View
2.
Brunt A, Haviland J, Wheatley D, Sydenham M, Alhasso A, Bloomfield D
. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020; 395(10237):1613-1626.
PMC: 7262592.
DOI: 10.1016/S0140-6736(20)30932-6.
View
3.
Braunstein L, Gillespie E, Hong L, Xu A, Bakhoum S, Cuaron J
. Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Adv Radiat Oncol. 2020; 5(4):582-588.
PMC: 7118660.
DOI: 10.1016/j.adro.2020.03.013.
View
4.
Brunt A, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A
. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol. 2016; 120(1):114-8.
PMC: 4998960.
DOI: 10.1016/j.radonc.2016.02.027.
View
5.
Polgar C, Kahan Z, Ivanov O, Chorvath M, Ligacova A, Csejtei A
. Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. Pathol Oncol Res. 2022; 28:1610378.
PMC: 9272418.
DOI: 10.3389/pore.2022.1610378.
View